Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bouffet

Showing results (441-450 of 533) with videos related to

Pageof 54
Sort By:
Cancer Cell|December 8, 2009
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumorsMeihua Li, Kyle F Lee, Yuntao Lu, et al.
Neuro-Oncology|July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumorsAnthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Neuro-Oncology|November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adultsDidier Frappaz, Girish Dhall, Matthew J Murray, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
The Lancet. Oncology|August 29, 2021
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort studySheena Mukkada, Nickhill Bhakta, Guillermo L Chantada, et al.
Neuro-Oncology|September 11, 2019
Molecular correlates of cerebellar mutism syndrome in medulloblastomaRashad Jabarkheel, Nisreen Amayiri, Derek Yecies, et al.
Acta Neuropathologica|June 5, 2012
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasDong-Anh Khuong-Quang, Pawel Buczkowicz, Patricia Rakopoulos, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
Canadian Consensus for Treatment of BRAF <i>V600E</i> Mutated Pediatric and AYA GliomasCraig Erker, Magimairajan Issai Vanan, Valérie Larouche, et al.
Pageof 54

Showing results (441-450 of 533) with videos related to

Sort By:
Pageof 54
Cancer Cell|December 8, 2009
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumorsMeihua Li, Kyle F Lee, Yuntao Lu, et al.
Neuro-Oncology|July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumorsAnthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Neuro-Oncology|November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adultsDidier Frappaz, Girish Dhall, Matthew J Murray, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
The Lancet. Oncology|August 29, 2021
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort studySheena Mukkada, Nickhill Bhakta, Guillermo L Chantada, et al.
Neuro-Oncology|September 11, 2019
Molecular correlates of cerebellar mutism syndrome in medulloblastomaRashad Jabarkheel, Nisreen Amayiri, Derek Yecies, et al.
Acta Neuropathologica|June 5, 2012
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasDong-Anh Khuong-Quang, Pawel Buczkowicz, Patricia Rakopoulos, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
Canadian Consensus for Treatment of BRAF <i>V600E</i> Mutated Pediatric and AYA GliomasCraig Erker, Magimairajan Issai Vanan, Valérie Larouche, et al.
Pageof 54